Moment Of Truth In EU For Amarin’s ‘Multi-Billion-Dollar Opportunity’ Drug

 
• By Neena Brizmohun

The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.

Heart disease in a person with obesity, conceptual image. 3D illustration showing increased weight male with obese heart
Vascepa is designed to lower cardiovascular risk • Source: Shutterstock

More from Product Reviews

More from Pink Sheet